| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.3 | 0.03 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.04 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.04 |